Hard & Veggie Capsules
High-speed automatic encapsulation for HPMC vegan, gelatin, enteric-coated, and delayed-release capsules. Sizes range from 000 to 4 with precision micro-dosing precision.
Q Nutritions operates state-of-the-art CDMO facilities engineered for high-efficiency nutraceutical production. Headquartered in Canada with an audited global supply network, we partner with overseas distributors, pharmacy chains, and premium dietary supplement brands requiring strict quality governance.
Every commercial batch undergoes multi-stage quality control—from identity testing of incoming raw actives via HPLC/ICP-MS to automated encapsulation, real-time weight check, and 100% finished product stability verification.
Pharmaceutical-grade processing machinery configured for high bioavailability, uniform dissolution, and consistent shelf stability.
High-speed automatic encapsulation for HPMC vegan, gelatin, enteric-coated, and delayed-release capsules. Sizes range from 000 to 4 with precision micro-dosing precision.
Rotary tablet presses producing chewable, effervescent, bi-layer, and film-coated tablets. Custom tooling, debossing, and modified-release options available.
Nitrogen-flushed manufacturing for omega-3 fish oils, MCTs, liposomal actives, and solubilized vitamins in gelatin or plant-based carrageenan shells.
Pectin and gelatin starchless deposit lines. Formulation capability for sugar-free, non-GMO, and active-rich vitamin gummies with thermal stability.
High-capacity V-blenders and ribbon mixers for proteins, greens, collagen, and amino acids. Automated filling into wide-mouth jars, sachets, and stick packs.
Aseptic liquid lines for nutritional shots, herbal drops, oral sprays, and functional syrups. Preservative-free processing with validated thermal pasteurization.
Built to handle the rigorous supply chain demands of global retail networks, importers, and brand owners.
A structured 4-stage execution model ensuring specification compliance at every manufacturing milestone.
Incoming active ingredients and excipients undergo strict FTIR identity verification, heavy metal screening, and micro testing prior to release.
Environmentally monitored HVAC cleanrooms maintain ideal temperature and humidity parameters for optimal blend uniformity and anti-caking performance.
In-process checks (weight variation, hardness, friability, disintegration) are logged every 30 minutes during encapsulation and tablet compression runs.
Finished goods are held until ISO 17025 laboratory CoA release. International export papers (Free Sale Certificate, Certificate of Origin) are issued.
Direct technical guidance on order requirements, compliance, and international shipping logistics.
Our standard production MOQs start at 1,000 units for encapsulated products, tablets, and softgels, 500 kg for custom powder blends, and 5,000 units for gummy lines. Lower volume pilot runs are available for clinical studies and stability testing validation.
Every commercial production run ships with a full Master Batch Record copy (upon request), a Certificate of Analysis (CoA) verified by third-party ISO 17025 accredited testing laboratories, Allergen Statements, BSE/TSE-Free Statements, and Product Specifications.
Yes. Our dedicated regulatory affairs department prepares registration documentation tailored to destination authority requirements, including Health Canada NPN applications, US FDA Supplement Facts panel compliance, EU food supplement notifications, and GCC registration dossiers.
Our facility operates negative-pressure ISO cleanrooms with HEPA air filtration. Standardized cleaning procedures require swab testing and analytical validation between production shifts to guarantee zero cross-contact for sensitive allergen-free, non-GMO, and vegan SKUs.
Speak with our senior pharmaceutical engineers and regulatory consultants to review your formula specifications, production feasibility, and custom quote options.